SCIENTIFIC HUB

Follow the evidence.

106.358 articles found

Open access

Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial.

Gendelman HE, Zhang Y, Santamaria P, Olson KE, Schutt CR, Bhatti D, Shetty BLD, Lu Y, Estes KA, Standaert DG, Heinrichs-Graham E, Larson L, Meza JL, Follett M, Forsberg E, Siuzdak G, Wilson TW, Peterson C, Mosley RL.

NPJ Parkinsons Dis · 2017-03-23

DOI: 10.1038/s41531-017-0013-5PMID: 28649610

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Parkinson disease.

Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE.

Nat Rev Dis Primers · 2017-03-23

DOI: 10.1038/nrdp.2017.13PMID: 28332488

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Phenotype of postural instability/gait difficulty in Parkinson disease: relevance to cognitive impairment and mechanism relating pathological proteins and neurotransmitters.

Zuo LJ, Piao YS, Li LX, Yu SY, Guo P, Hu Y, Lian TH, Wang RD, Yu QJ, Jin Z, Wang YJ, Wang XM, Chan P, Chen SD, Wang YJ, Zhang W.

Sci Rep · 2017-03-23

DOI: 10.1038/srep44872PMID: 28332604

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.